Ian Dixon

Directeur/Membre du Conseil chez NYRADA INC. Fortune : 4 M $ au 31/05/2026

Profil

Ian Dixon was the founder of Genscreen Pty Ltd. founded in 2002, Cynata, Inc. founded in 2011, Exopharm Ltd. founded in 2013 where Dr. Dixon was Chief Executive Officer, Director & MD from 2013 to 2024, and Cardio Therapeutics Pty Ltd. founded in 2014.
Dr. Dixon is currently Managing Director at Altnia Holdings Pty Ltd., Independent Non-Executive Director at Nyrada, Inc. since 2020, and a Member of the Australia Institute of Co. Directors.
Former positions include Executive Director at Medigard Ltd., Director-Product Group at Vision Systems Pty Ltd., Non-Executive Director at Cell Therapies Pty Ltd., Non-Executive Director at Noxopharm Ltd. from 2016 to 2020, and Owner at Cynata Therapeutics Ltd. Education includes a doctorate from Monash University and undergraduate and MBAistration degrees from Swinburne University of Technology.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
NYRADA, INC. 8,94 %	20/02/2026	9 780 699 ( 8,94 % )	4 M $	31/05/2026

Postes actifs de Ian Dixon

Sociétés	Poste	Début
NYRADA INC.	Directeur/Membre du Conseil	01/09/2020
Altnia Holdings Pty Ltd.	Corporate Officer/Principal	-
Australia Institute of Co. Directors	Corporate Officer/Principal	-

Anciens postes connus de Ian Dixon

Sociétés	Poste	Fin
EXOPHARM	Fondateur	01/05/2024
NOXOPHARM LIMITED	Directeur/Membre du Conseil	31/08/2020
Genscreen Pty Ltd.	Fondateur	01/01/2018
CYNATA THERAPEUTICS LIMITED	Corporate Officer/Principal	-
Cardio Therapeutics Pty Ltd.	Fondateur	-